课题基金 / 基金详情

Decreased expression of TCRζ and signal transduction due to the aberrantexpression of the TCR mRNA in SLE patient T cells

Decreased expression of TCRζ and signal transduction due to the aberrantexpression of the TCR mRNA in SLE patient T cells
由于 SLE 患者 T 细胞中 TCR mRNA 的异常表达,TCR z 的表达和信号转导降低
批准号:
16590993
负责人:
TSUZAKA Kensei
金额:
$2.44万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2007

项目摘要

项目成果

TSUZAKA Kensei的其他基金

相似基金

相关文献

中文摘要
翻译
我们最近报道,在系统性红斑狼疮患者中,T细胞受体ζ链(ζ)的表达显著降低或缺失,这是由于ζ基因剪接变异体与交替剪接的短3‘非编码区(ζ)或外显子7缺失(ζ/EX7-)所致。在此,我们利用逆转录病毒系统研究了包括ζ在内的TcR/CD3的表达。因此,包括ζ在内的T细胞TcR/CD3mRNA/EX7-的表达和IL-2的产生由于ζmRNAEX7-的不稳定性而显著降低。为了验证包括ζ在内的TcR/CD3复合体的减少或缺失是否表现出提示ζ的差异转录模式,我们通过基因芯片分析比较了基因表达谱。结果表明,在ζ基因剪接变异体的转染体中,Syndecan-1、颗粒酶A、硒结合蛋白和溶质载体家族4基因普遍上调。另一方面,几种细胞因子(IL-2…)的表达IL-15、IL-18、转化生长因子-β)降低。因此,在T细胞中发现这些应答基因,并伴随包括ζ在内的TcR/CD3复合体的下调,可能有助于更好地了解T细胞功能障碍和系统性红斑狼疮的发病机制。因此,Sdc1、Sdc2和Sdc3在SLE患者T细胞和健康对照组之间的表达模式没有观察到差异。然而,在11例SLE患者T细胞中,有10例在抗SDC4抗体检测到的35kD和40kD蛋白条带缺失。10例系统性红斑狼疮患者经抗Ζ抗体免疫印迹法检测,ζ基因缺失。该SDC4相关的35-kD蛋白在抗HS抗体处理后被吸收。FACS分析显示,12例SLE患者中有9例细胞表面HS和SDC4减少或缺失。有趣的是,在这9例SLE患者T细胞中,有报道将N-乙酰氨基葡萄糖(GlcNAc)转移到SDC家族核心蛋白的公共连接物四糖的Exostosin-like 2(EXTL2)酶的产生显著减少或缺失。较少
英文摘要
We recently reported that expression of the T-cell receptor ζ chain (ζ) was significantly decreased or absent in systemic lupus erythematosus (SLE) patients due to the ζ mRNA splice variants with alternatively spliced short 3'UTR (ζ mRNA/as-3'UTR) or with deletion of exon7 (ζ mRNA/ex7-). Here we investigated the expression of TCR/CD3 including ζ by using retrovirus systems. As a result, the expression of TCR/CD3 including ζ and IL-2 production from ζ mRNA/ex7- was significantly decreased due to the instability of ζ mRNA/ex7-.To examine whether these T cells with decreased or absent of TCR/CD3 complex including ζ exhibit differential transcription patterns that are indicative of SLE, we compared the gene expression profile by DNA microarray analysis. As a result, genes of syndecan-1 (Sdc-1), granzyme A, selenium binding protein, and solute carrier family 4 were up-regulated commonly in the transfectant with ζ mRNA splice variant froms. On the other hand, those of several cytokines (IL-2 … More , IL-15, IL-18, TGF- β) and were decreased. From these observations, identification of these responsive genes in T-cells accompanied by the down-regulation of TCR/CD3 complex including ζ may help to better understand the mechanism underlying T-cell dysfunction and pathogenesis of SLE.We investigated the expression of Sdc families (Sdc-1 through Sdc-4) in SLE T cells by using Western blot (WB). As a result, there observed no differences in the expression patterns of Sdc1, Sdc2, and Sdc3 between in SLE patient T cells and in healthy normal controls. However, the 35- and 40-kD protein bands detected with anti-Sdc4 antibody were missing in 10 out of 11 SLE patient T cells. Ζ was also missing in these 10 SLE patients by WB using anti-ζ antibody. This Sdc4-related 35-kD protein was absorbed after the treatment of anti-HS antibody. In FACS analysis, cell surface HS and Sdc4 was decreased or missing in 9 out 12 SLE patients. Interestingly, the production of exostosin-like 2 (EXTL2) enzyme, which has been reported to transfer N-acetylglucosamine (GlcNAc) to the common linker tetrasaccharide of a core protein of Sdc families, was significantly reduced or missing in these 9 SLE patient T cells. Less
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
DNA microarray gene expression profile of T cells with the splice variants of TCR mRNA observed in SLE
SLE 中观察到的 T 细胞 DNA 微阵列基因表达谱以及 TCR mRNA 剪接变异体
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [Tsuzaka, K, Setoyama, Y, Yoshimoto, K, et. al.]
通讯作者: et. al.
TCRゼータ鎖ヴァリアントに起因する二次的分子異常の検索
寻找TCR zeta链变异引起的二级分子异常
DOI: --
发表时间: 2006
期刊: リウマチ科 35
影响因子: --
作者: [Tsuzaka, K, Nozaki, K, Kumazawa, C, et. al., Tsuzaka Kensei, Yoshimoto Keiko, Tsuzaka Kensei, 津坂憲政]
通讯作者: 津坂憲政
A splice variant of the TCR mRNA lacking exon 7 leads to the down-regulation of TCRζ, the TCR/CD3 complex, and IL-2 production in SLE T cells.
缺乏外显子 7 的 TCR mRNA 剪接变体会导致 SLE T 细胞中 TCR z、TCR/CD3 复合物和 IL-2 产生的下调。
DOI: --
发表时间: 2005
期刊: J Immunol 174
影响因子: --
作者: [Tsuzaka, K, Setoyama, Y, Yoshimoto, K, et. al.]
通讯作者: et. al.
Therapeutic targets in misguided T cells in systemic lupus erythematosus
系统性红斑狼疮中误导性 T 细胞的治疗靶点
DOI: --
发表时间: 2005
期刊: Current Drug Target 4
影响因子: --
作者: [Takeuchi, T, Tsuzaka, K, Kameda, H, et. al.]
通讯作者: et. al.
23
    Mechanism of systemic lupus erythematosus accompanied with the aberrant TCR zeta mRNA 3'UTR
    • 批准号:
      21591268
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2009
    • 负责人:
      TSUZAKA Kensei
    • 依托单位:
    Analysis of the aberrant TCRζ mRNA 3'UTR in SLE patient T cells
    • 批准号:
      12670436
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2000
    • 负责人:
      TSUZAKA Kensei
    • 依托单位:
    国内基金
    海外基金
    高效Mage转座系统赋能KRAS G12D突变结直肠癌新型TCR-T疗法开发临床前研究
    双靶向CAR-TCR-T疗法克服小细胞肺癌肿瘤异质性的机制探索
    • 批准号:
      JCZRLH202601115
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    Piezo1驱动的人工合成TCR-T精准靶向肝癌的治疗研究
    • 批准号:
      2026JJ60274
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      肖潺潺
    • 依托单位:
    靶向PIK3CA突变的TCR-TCE NV制备及其在妊娠乳腺癌治疗中的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李罗
    • 依托单位: